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1875-9572/Copyright ª 2014, TaiwanBackground: Due to the increase of breastfeeding in infants, iron deficiency anemia (IDA)
related to prolonged, predominant breastfeeding should be of concern. Mostly, the manifesta-
tion of IDA is indistinguishable and the enthusiastic advocacy of breastfeeding without concom-
itant education of complementary food may lead to ignorance of breast milk-related IDA,
which may result in impaired psychomotor development of the baby. This retrospective study
was conducted to re-emphasize this easily ignored but still prevalent illness.
Methods: This retrospective study involved 15 breastfeeding babies who were diagnosed with
IDA between January 2007 and December 2010 at age 6e18 months. The clinical presentation,
age at diagnosis, initial hemoglobin level and mean corpuscular volume, growth percentile,
and duration of treatment were recorded and analyzed.
Results: None of the babies was suspected to have anemia by caregivers. Pallor was noticed by
physicians in nine patients; one patient had seizure, one patient had pica, and, for the remain-
ing four patients, IDA was diagnosed incidentally due to other medical events. Oral iron sup-
plementation for an average of 3.6 months improved both hemoglobin level (from 8.0 g/dL
to 11.5 g/dL) and mean corpuscular volume (from 57.5 fL to 73.9 fL). Most babies had appro-
priate growth and normal neurological development; two babies had both IDA and thalassemia.
Conclusion: Although the association of IDA with prolonged, predominant breastfeeding is well
known, its presentation is so subtle that its detection relies mainly on alert medical personnel.
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reserved.of Pediatrics, Taipei Veterans G
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Iron deficiency is the most common micronutrient defi-
ciency and the most common cause of anemia in child-
hood.1 Iron is important for both growth and development
of the infants. Ferropenic anemia caused by severe iron
deficiency in infancy is associated with impaired health
and serious neurological impairment, such as mental,
motor, social, emotional, neurophysiological, and neuro-
cognitive dysfunction.2 In general, infants born at term
with adequate birth weight have sufficient iron stores for
the first 4e6 months of life, the recommended period of
exclusive breastfeeding by the World Health Organization
(WHO).3 Breast feeding in this period reduces infant
mortality that is caused by common childhood illnesses
such as diarrhea and pneumonia,4 and it also hastens
children’s recovery from illness. After age 6 months, as
the children grow with concomitant expansion of blood
volume, the body iron stores are depleted while body iron
demand is increased; thus breast milk becomes insuffi-
cient for iron supply. Therefore, infants who are pre-
dominantly breastfed beyond age 6 months are potentially
prone to have iron deficiency anemia (IDA)5; the addition
of sufficient complementary foods is essential for infant
growth at this time.
Due to the enthusiastic advocacy of breastfeeding in our
society, the population of breastfed infants is increasing.
Therefore, IDA related to prolonged predominant breast-
feeding should be of concern in infant care. The manifes-
tation of IDA is always indistinguishable; therefore, its
detection relies mostly on the alertness of physicians. In
this retrospective study, 15 cases of IDA are collected; the
manifestations, diagnostic process, and treatment re-
sponses are presented.2. Methods
This is a retrospective chart review study. From January
2007 to December 2010, fifteen babies were analyzed at
the age of 6e18 months; 10 were male and five female. The
enrollment criteria was as follows: predominant breast-
feeding beyond 6 months of age; presence of microcytic
anemia [hemoglobin (Hb) <11 g/dL and mean corpuscular
volume (MCV) <70 fL]; and confirmation of IDA through
laboratory test or presence of adequate response to iron
therapy. The laboratory criteria are ferritin <15 ng/mL,
and adequate response to iron therapy is defined as in-
crease in Hb level by 1 g/dL after 1 month of appropriate
iron-replacement therapy.6 Three were full-term babies,
whose mean birth body weight was 3126  692 g; and 12
were preterm babies (gestational age <37 weeks) including
one pair of twins and a single twin, whose mean birth body
weight was 1858  417 g. Predominant breastfeeding was
defined as scanty addition of complimentary food. None of
the babies had gross bloody stools, hematuria, or other
bleeding events.
The clinical presentation, age at diagnosis, initial Hb
levels and MCV, growth percentile, and duration of treat-
ment were recorded and analyzed.3. Results
Table 1 shows the baseline characteristics and laboratory
data of all patients. In nine cases, anemia was suspected by
pediatricians owing to pallor; in four patients, anemia was
detected on routine blood tests for other diseases such as
fever, urinary tract infection, and respiratory tract infec-
tion. One patient had seizure, and pallor was noticed by the
physician; another had pica, which was manifested as
eating paper.
Confirmation of IDA through complete laboratory checks
such as ferritin/iron levels and total iron-binding capacity
(TIBC) were available in eight cases only. The mean values
in these patients were as follows: ferritin 9.2 ng/mL (range,
0.4e53.0 ng/mL; normal, <15 ng/mL); iron 15.6 mg/dL
(range, 7e27 mg/dL; normal, 40e100 mg/dL); and TIBC
462 mg/dL (range, 378e606 mg/dL; normal, 100e400 mg/
dL). The only patient with normal ferritin level (53.0 ng/
mL) at diagnosis was a case of pneumonia. Her initial iron
level was low (14 mg/dL) and TIBC was borderline (378 mg/
dL). She had normalization of both hemoglobin and MCV
after iron therapy for 2 months; therefore, this case was
enrolled. Excluding these extreme data, which might be a
response to infection, the mean value of ferritin in this
group was 2.97 ng/mL (range 0.4e6.34 ng/mL). In the
remaining seven patients, IDA was confirmed through
therapeutic response. After iron therapy for an average
duration of 4 months (range, 2e6 months), their Hb
increased from 8.15 g/dL to 11.6 g/dL; and their MCV
increased from 58 fL to 75 fL. The therapeutic iron trial
remains the most cost-effective strategy for the diagnosis
of IDA in patients with mild microcytic anemia.7
Hb electrophoresis and staining for Hb H inclusion bodies
were performed to exclude thalassemia in eight patients
who had positive family history; one patient had a-thalas-
semia, and another had b-thalassemia. For the case with a-
thalassemia, the initial laboratory data were Hb 9.7 g/dL,
MCV 69 fL, and Hb H stain positive; after 2 months of iron
therapy, the Hb level was 12.1 g/dL, and MCV was 80 fL.
Possibly, the baby had a-thalassemia trait, which is caused
by the deletion of two a genes; MCV reduction in such cases
may be borderline. The initial laboratory data in the pa-
tient with b-thalassemia were as follows: ferritin, 0.77 ng/
mL; iron, 27 mg/dL; TIBC, 399 mg/dL; Hb A, 87.4%; Hb A2,
6%; and Hb F, 6.6%. After 2 months of iron therapy with poor
compliance, no definite response was elicited, and the
patient was lost to follow-up.
The mean postnatal age at IDA diagnosis was 10.5
months: 9.0 months in the full-term babies, and 10.8
months in the preterm babies. The average initial Hb level
was 8.0 g/dL (full-term group, 8.6 g/dL; preterm group,
7.9 g/dL), and the average initial MCV was 57.5 fL (full-
term group, 62.0 fL; preterm group, 56.4 fL). All babies
received oral iron supplements (Ferrum Hausmann drops
50 mg/mL) at a dose of 4e6 mg/kg/day. The average
duration of treatment was 3.6 months (range 2e6 months).
After treatment, the average Hb level was 11.5 g/dL, and
the average MCV was 73.9 fL (Table 1). All the babies,
except for the case with b-thalassemia who was lost to
follow-up, were free from neurological sequelae. Most of
Table 1 Young children with iron deficiency anemia.
Case no. Sex GA (wk) Age at
Dx (mo)
Presentation Hb at
Dx (g/dL)
Hb after
Tx (g/dL)
MCV at
Dx (fL)
MCV after
Tx (fL)
Iron
Tx (mo)
Comments
Full-term
1 M 37 þ 6 7 Pallor 8.4 11.2 68 76 4.5
2 M 37 þ 6 8 Pallor 7.9 9.9 57 64 2
3 M 38 12 Pallor 9.6 10.9 61 68 2.5
Mean  SD
(range)
9.0  2.2
(7e12)
8.6  0.7
(7.9e9.6)
10.6  0.6
(9.9e11.2)
62.0  4.5
(57e68)
69.3  5.0
(64e76)
3.0  1.1
(2e4.5)
Preterm
4 M 31 þ 2 6 Pallor 7.5 11.9 59 71 3
5 M 31 þ 2 8 Pallor 7.0 12.4 55 70 3
6 M 32 8 Pallor 6.6 10.5 51 79 2
7 M 32 14 Pallor 6.2 11.6 49 74 5 Twin A
8 F 30 16 Incidental Dx 9.7 12.1 69 80 2 Twin A,
a-thalassemia
9 F 30 16 Incidental Dx 8.6 11.3 61.7 77 2 Twin B
10 M 32 þ 3 6 Seizure 6.3 11.5 50 76 3
11 F 33 9 Incidental Dx 7.1 12.3 50.5 81 5
12 M 35 þ 6 9 Incidental Dx 7.7 12.4 52.3 80 6
13 M 36 12 Pallor 10.4 10.7 60 60 2 b-thalassemia
14 F 36 þ 6 9 Pallor 7.8 12.1 56 74 6
15 F 36 þ 5 17 Pica 10.2 11.7 63 78 6
Mean  SD
(range)
10.8  3.8
(6e17)
7.9  1.4
(6.2e10.4)
11.7  0.6
(10.5e12.4)
56.4  6.0
(49e69)
75  5.7
(70e81)
3.8  1.6
(2e6)
DxZ diagnosis; GAZ gestational age; HbZ hemoglobin; MCVZ mean corpuscular volume; SDZ standard deviation; TxZ treatment.
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within the 3rde85th percentile in mode; three preterm
cases had body height <3rd percentile and one also had
body weight <3rd percentile. After iron therapy, there was
no remarkable change in their growth status, possibly due
to the short duration of observation.4. Discussion
A variety of heterogeneous agents that possess antimicro-
bial activity are found in human milk. As a result, infants
who are exclusively breastfed in the initial 4 months of life
have fewer episodes of diarrhea, otitis media, pneumonia,
bacteremia, and meningitis during the 1st year of life in
comparison with infants who are formula-fed.8e10 In addi-
tion, breastfeeding facilitates the maternaleinfant rela-
tionship, and its psychological advantages are well
recognized. Owing to its numerous beneficial effects on
infant health, exclusive breastfeeding is recommended
during the initial 4e6 months of life by WHO.3 However, the
iron content of human milk is low (0.2e0.4 mg/L); so iron
depletion is a potential risk in infants who are predomi-
nantly or exclusively breastfed beyond age 6 months.
Before this age, the better absorption of breast milk iron
and the iron stores in most full-term babies may prevent
iron deficiency.11,12 Calvo et al5 reported that, at age 6
months, IDA was detected in 44.0% of the breastfed babies,
but only in 14.3% of the formula-fed babies; at 9 months,
the incidence was 27.8% and 7.1%, respectively. Preterm
infants, who have smaller iron stores, more iatrogenic
blood loss during the neonatal period, and faster growthrates thereafter, are at higher risk of developing IDA.5 In
this study, 80% of the cases were preterm babies, whose
initial Hb levels and MCV were lower than the term babies
(Hb, 7.9 g/dL vs. 8.6 g/dL; MCV, 56.4 fL vs. 62.0 fL). Other
risk factors for IDA include maternal anemia, previous blood
loss, low birth weight, and being fed cow’s milk instead of
breast or formula milk before the age of 1 year.13e15
A survey conducted in Taiwan showed that 45.6% of 6-
month-old babies were exclusively breastfed in 2011.16
Physicians should be vigilant for the possibility of IDA in
these babies. To prevent IDA, breastfed infants should
receive iron supplementation in the form of complemen-
tary infant foods such as iron-fortified cereals, red meat, or
egg after age 6 months; and they should be offered iron-
fortified infant formula after weaning breast milk. Both
the WHO3 and the Taiwan Pediatric Association17 emphasize
the addition of iron-fortified and zinc-fortified foods for
breastfed infants after age 4e6 months.
The treatment of IDA includes dietary changes as well as
iron administration. Under good compliance to therapy, the
increase in Hb by 1 g/dL after 4 weeks of iron supplemen-
tation can confirm the diagnosis of IDA.6 The potential
causes of failure of response include incompliance with
therapy and coexistence of other diseases such as a- and b-
thalassemia, which affect approximately 6e8% and 1e2% of
the Taiwanese population, respectively.18 In this study, all
babies except for the one with b-thalassemia showed a
good response to iron therapy; the initial presentation,
including pallor, seizure, or pica, resolved with an increase
in Hb and MCV. Oral iron supplementation is recommended
for an additional 2 months after Hb levels return to the
normal range for the child’s age10; however, most patients
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appearance of these patients may make the caregivers feel
complacent and lead to premature cessation of iron sup-
plementation. Physicians should take greater responsibility
in advocating complete treatment.
Because this was a retrospective case-collection study,
we could not determine the true prevalence of IDA in in-
fants or compare breastfed and formula-fed babies.
Because the manifestations of IDA are subtle, both the
caregivers and the pediatricians may miss the detection or
be loose in compliance with therapy. Our study is to re-
emphasize the importance of this historic disease. Educa-
tion of adding iron-fortified supplement food at 4e6 months
old should be included in the advocacy of breastfeeding to
decrease the occurrence of IDA in infants.
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